Alterity Therapeutics-ADRATHE
13F holders, Q1 2024 (March 31)10holders
1famous investor
$2.06avg. 13F price*
At the end of Q1 2024, 10 institutions reported holding Alterity Therapeutics-ADR (ATHE) in their 13F filings. The largest holders were Morgan Stanley ($108K), Citadel Advisors ($37K) and XTX Topco Ltd ($36K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Alterity Therapeutics-ADR
- CUSIP
- 02155X205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $73K |
| Exits | 2 | $74K |
Ownership 10 holders
| Morgan Stanley | 0.00% | Reduce -5.6% | 51,985 | $108K |
| Citadel Advisors | 0.00% | New | 18,279 | $37K |
| XTX Topco Ltd | 0.00% | New | 17,425 | $36K |
| Twin Lakes Capital Management, LLC | 0.01% | No change | 5,925 | $12K |
| Providence Capital Advisors, LLC | 0.00% | No change | 200 | $414 |
| Osaic Holdings, Inc. | 0.00% | No change | 81 | $165 |
| Sugarloaf Wealth Management, LLC | 0.00% | No change | 33 | $68 |
| CoreCap Advisors, LLC | 0.00% | New | 21 | $43 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 6 | $12 |
| UBS Group AG | 0.00% | New | 2 | $4 |
"% of holder's portfolio" is ATHE's weight in each manager's 13F, not the share of Alterity Therapeutics-ADR the manager owns.